Long-term Study of FK949E in Elderly Patients -Long-term Study in Elderly Bipolar Disorder Patients With Major Depressive Episodes-
Phase of Trial: Phase III
Latest Information Update: 03 Nov 2017
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 09 Aug 2016 Status changed from active, no longer recruiting to completed.
- 09 Jul 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 07 Jan 2013 New trial record